[1]
MICHAEL and D. L. RAMATILLAH, “TREATMENT PROFILE AND SURVIVAL ANALYSIS ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) COVID-19 PATIENTS”, Int J App Pharm, vol. 14, no. 2, pp. 54–56, Apr. 2022.